Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study.

Yang H, Bouma BJ, Dimopoulos K, Khairy P, Ladouceur M, Niwa K, Greutmann M, Schwerzmann M, Egbe A, Scognamiglio G, Budts W, Veldtman G, Opotowsky AR, Broberg CS, Gumbiene L, Meijboom FJ, Rutz T, Post MC, Moe T, Lipczyńska M, Tsai SF, Chakrabarti S, Tobler D, Davidson W, Morissens M, van Dijk A, Buber J, Bouchardy J, Skoglund K, Christersson C, Kronvall T, Konings TC, Alonso-Gonzalez R, Mizuno A, Webb G, Laukyte M, Sieswerda GTJ, Shafer K, Aboulhosn J, Mulder BJM.

Int J Cardiol. 2019 Jun 13. pii: S0167-5273(18)37020-7. doi: 10.1016/j.ijcard.2019.06.014. [Epub ahead of print]

2.

Epidemiological changes in Eisenmenger syndrome in the Nordic region in 1977-2012.

Hjortshøj CS, Jensen AS, Sørensen K, Nagy E, Johansson B, Kronvall T, Dellborg M, Estensen ME, Holmstrøm H, Turanlahti M, Thilén U, Søndergaard L.

Heart. 2017 Sep;103(17):1353-1358. doi: 10.1136/heartjnl-2016-310979. Epub 2017 Apr 27.

PMID:
28450553
3.

Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature.

Eriksson C, Gustavsson A, Kronvall T, Tysk C.

J Gastrointestin Liver Dis. 2011 Mar;20(1):77-80. Review.

4.

Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil.

Lindholm CJ, Fredholm O, Möller SJ, Edvardsson N, Kronvall T, Pettersson T, Firsovaite V, Roijer A, Meurling CJ, Platonov PG, Olsson SB.

Heart. 2004 May;90(5):534-8.

Supplemental Content

Loading ...
Support Center